CT Lung Nodule Assessment (LNA)

Assessing lung nodules over time

Enables review and analysis of thoracic CT images, providing segmentation, quantification and characterization of physician-indicated lung nodules. The application can be used in both diagnostic and screening evaluations, supporting Low Dose CT Lung Cancer Screening*

 lung nodule assessment thumbnail

Benefits

  • Automatic lung and lobes segmentation and one click 2D and 3D nodule segmentation.
  • Supports LungRADS categorization, Fleischner Society guidelines for incidental findings as well as a Risk Calculator tool**.
  • Pre-filled data including characteristics for each nodule in configurable presets are provided automatically by the application.
  • Lung and nodule segmentations can be shared as RT Structures.

* The screening must be performed within the established inclusion criteria of programs/protocols that have been approved and published by either a governmental body or professional medical society. Please refer to clinical literature, including the results of the National Lung Screening Trial (N Engl J Med 2011; 365:395-409) and subsequent literature, for further information.
** Based on patient and nodule characteristics for estimation of the probability that lung nodules detected on baseline screening low-dose CT scans are malignant. These functionalities may not be available in all territories. Please contact a Philips representative for more details.

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

Jūs pateksite į Lietuvos „Philips Healthcare“ svetainę.
Please select the checkbox

Svetainė skirta tik asmenims, naudojantiems medicinos priemones profesinėje veikloje, įskaitant sveikatos priežiūros specialistams, profesinę veiklą vykdantiems asmenims, atstovaujantiems sveikatos priežiūros įstaigą ar medicinos priemonėmis prekiaujančią organizaciją.

Ar esate asmuo, atitinkantis aukščiau nurodytus kriterijus?